Click to Share
 
 
  1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution

therapeutics Press Releases

  + XML/RSS  



By Amyndas Pharmaceuticals
Amyndas Pharmaceuticals SA, the complement therapeutics company, announced that the European Medicines Agency (EMA) has granted AMY-101, a potent complement C3 inhibitor, an Orphan Drug Designation for the treatment of Paroxysmal Nocturnal Hemoglobinuria.

By SMi Group
SMi Group have worked together with an esteemed panel of speakers including KOLs from Merck, Janssen Pharmaceuticals, Imperial College London, Mundipharma, Nektar Pharmaceuticals, Morpheus and Eli Lilly, to put together the conference agenda for the 14th.

By Reportstack
Reportstack's new report estimates that the value of the epilepsy market in the APAC region amounted to an estimated $1.1 billion in 2012 and is expected to register a Compound Annual Growth Rate (CAGR) of 4.7% to reach $1.5 billion by 2019.

By Reportstack
Gastrointestinal Therapeutics in Asia-Pacific Markets to 2019 - Strong Potential for Pipeline Biologics on Account of High Regional Unmet Need

By AhR Pharmaceuticals, Inc.
AhR Pharmaceuticals Announces the Issuance of Its First Own Patent by United States Patent and Trademark Office (USPTO)

By Reportstack
Increasing Prevalence and Promising Novel Drugs offset Patent Cliff Threat

By Cambridge Healthtech Institute
Chemical Computing Group will host a dinner short course in Boston, MA, on June 19, 2013, from 6:00-8:00 pm, on the conclusion of day one of CHI/Bio-IT World’s 13th annual Structure-Based Drug Design (SBDD) conference taking place at the Revere Hotel...

By Aarkstore Enterprise
Aarkstore announce a new report "Gallbladder Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2018 " through its vast collection of market research report.

By Cambridge Healthtech Institute
CHI's Regulatory Approval of a Therapeutic & Companion Diagnostic: Nuts & Bolts Short Course is being held at the Molecular Med TRI-CON 2013 on February 12th at the Moscone North Convention Center in San Francisco.

By Arrogene, Inc.
Arrogene's innovative multi-target nano-platform for cancer therapeutics to be discussed at the 2012 Techconnect World Nanotechnology Conference.

By Therapeutics
Therapeutics is pleased to announce the launch of their new gait analysis service which is run by the biomechanist Kim Lilley at the physiotherapy and sport injury clinic based in the UK.

By Cambridge Healthtech Institute
Two thought-leaders and experts on phase II clinical trials will be the keynote speakers at the CHI’s Accelerating Proof of Concept: Clinical Success Driven by Science & Strategy, set for October 3-5 at the Crowne Plaza Hotel in Philadelphia, PA.

All Press Releases

By Amyndas Pharmaceuticals
Amyndas Pharmaceuticals SA, the complement therapeutics company, announced that the European Medicines Agency (EMA) has granted AMY-101, a potent complement C3 inhibitor, an Orphan Drug Designation for the treatment of Paroxysmal Nocturnal Hemoglobinuria.

By SMi Group
SMi Group have worked together with an esteemed panel of speakers including KOLs from Merck, Janssen Pharmaceuticals, Imperial College London, Mundipharma, Nektar Pharmaceuticals, Morpheus and Eli Lilly, to put together the conference agenda for the 14th.

By Reportstack
Reportstack's new report estimates that the value of the epilepsy market in the APAC region amounted to an estimated $1.1 billion in 2012 and is expected to register a Compound Annual Growth Rate (CAGR) of 4.7% to reach $1.5 billion by 2019.

By Reportstack
Gastrointestinal Therapeutics in Asia-Pacific Markets to 2019 - Strong Potential for Pipeline Biologics on Account of High Regional Unmet Need

By AhR Pharmaceuticals, Inc.
AhR Pharmaceuticals Announces the Issuance of Its First Own Patent by United States Patent and Trademark Office (USPTO)

By Reportstack
Increasing Prevalence and Promising Novel Drugs offset Patent Cliff Threat

By visiongain
A new report by visiongain predicts the world market for Alzheimer’s disease therapeutics and diagnostics will reach $8.3bn in 2017. That revenue forecast and others appear in Alzheimer’s Disease Therapeutics and Diagnostics.

By Cambridge Healthtech Institute
Chemical Computing Group will host a dinner short course in Boston, MA, on June 19, 2013, from 6:00-8:00 pm, on the conclusion of day one of CHI/Bio-IT World’s 13th annual Structure-Based Drug Design (SBDD) conference taking place at the Revere Hotel...

By Aarkstore Enterprise
Aarkstore announce a new report "Gallbladder Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2018 " through its vast collection of market research report.

By Arrowhead Publishers and Conferences
The 3rd Annual Traumatic Brain Injury Conference will be held on March 6-7, 2013 in Washington, DC. The conference will provide a holistic perspective on the diagnosis, treatment and outcomes associated with traumatic brain injury.

By Cambridge Healthtech Institute
CHI's Regulatory Approval of a Therapeutic & Companion Diagnostic: Nuts & Bolts Short Course is being held at the Molecular Med TRI-CON 2013 on February 12th at the Moscone North Convention Center in San Francisco.

By Therapeutics Southampton
On Saturday 4th August, Stroke Survivors Southampton / Different Strokes Southampton (a local charity) and Therapeutics Southampton (a fitness and rehabilitation gym) hosted a sponsored charity walk.

By Articulon
NUTECH 2012 to be held at the NC Biotechnology Center on October 4.

By Rajesh Gunnam
Endometriosis Therapeutics Market is Forecast to Show Steady Growth Until 2018

By Aarkstore Enterprise
MarketAark - announces report of Disease and Therapy Review: Parkinson's Disease and also avaliable SAMPLE PAGE of the Report

By Arrogene, Inc.
Arrogene's innovative multi-target nano-platform for cancer therapeutics to be discussed at the 2012 Techconnect World Nanotechnology Conference.

By ReportReserve
the industry analysis specialist, has released its new report, “Neuroendocrine Carcinoma Therapeutics - Pipeline Assessment and Market Forecast to 2019”.

By Bharatbook
Bharatbook.com introduces a report " Endocrinology Market to 2018 " The report provides an in-depth analysis of the major endocrine markets including growth hormone deficiency market, acromegaly market.

By Bharatbook
Bharatbook.com introduces a report " Diabetes Therapeutics Market to 2017 " Better Glycemic Control and Reduced Potential Risk of Hypoglycemia to Increase the Market Share of DPP-IV Inhibitors and GLP-1 Agonists

By Cambridge Healthtech Institute
This event will take place prior to the start of the Next Generation Dx Summit: Moving Assays to Clinic (August 21-23).

By Fast Market Research, Inc.
New Pharmaceuticals market report from GlobalData: "Joint Pain Global Clinical Trials Review, H1, 2012"

By SMi Group Ltd
Join SMi at the 12th annual Pain Therapeutics conference, which will be held on 21st & 22nd May 2012 in London, UK.

By ReportsnReports
Global Data's report"Chemotherapy-Induced Nausea and Vomiting (CINV) Therapeutics - Pipeline Assessment and Market Forecasts to 2019" is now available with ReportsnReports.com database

By Arrowhead Publishers and Conferences
FDA's Lead Reviewer for DONED to Give Regulatory Perspective on Development & Validation of Diagnostic Devices for Traumatic Brain Injury at 2nd Annual TBI Conference

By SMi Group
Imaging in Cancer Drug Development will offer an excellent arena to discuss challenges, compare techniques and gain valuable information on how this field is developing and how advances may be of benefit in the future.

By Joe Walsh
Piribo, the online destination for Pharma intelligence, has added a new report.

By bharatbook
Bharatbook added a new report on " Early Stage Drug Discovery in Disease Segments - Innovation Focuses on Stem Cell Therapies and Gene Therapies " which gives an overview, Demand, Supply Trends and industry analysis reports.

By Therapeutics
A new advice service has been launched by Southampton-based physiotherapy and sports injury clinic Therapeutics, providing a breakthrough service for clients in need of quick and convenient treatment.

By bharatbook
Bharatbook added a new report on " Global HIV Therapeutics Market Analysis " which gives an overview, Demand, Supply Trends and industry analysis reports.

By Joe Walsh
Piribo, the online destination for Pharma intelligence, has added a new report.

By Therapeutics
Therapeutics is pleased to announce the launch of their new gait analysis service which is run by the biomechanist Kim Lilley at the physiotherapy and sport injury clinic based in the UK.

By Cambridge Healthtech Institute
Two thought-leaders and experts on phase II clinical trials will be the keynote speakers at the CHI’s Accelerating Proof of Concept: Clinical Success Driven by Science & Strategy, set for October 3-5 at the Crowne Plaza Hotel in Philadelphia, PA.

By Arrowhead Publishers and Conferences
For the past four years, this conference has provided attendees with thoughtful insight from key industry leaders and academic researchers.

By Fast Market Research
New Pharmaceuticals market report from GlobalData: "Sepsis Global Clinical Trials Review, Q2, 2011"

By Sarah Brereton, Limewash Media & Design
Isogenica, Biolauncher and Cresset Biomolecular Discovery forge alliance to bring powerful target-to-drugs platform to market. Joint venture aims to rapidly identify small molecule therapeutics to pharma targets.

By Fast Market Research
New Pharmaceuticals research report from GlobalData is now available from Fast Market Research

By Fast Market Research
New Pharmaceuticals market report from GlobalData: "Retinal Vein Occlusion (RVO) Therapeutics - Pipeline Assessment and Market Forecasts to 2017"

By Fast Market Research
Recently published research from GlobalData, "HIV-AIDS Therapeutics - Pipeline Assessment and Market Forecasts to 2017", is now available at Fast Market Research

By Integrative Therapeutics
Natural Medicine Company Integrative Therapeutics, Inc. Offers Up to $1,000 for Practitioners to Join in the Mission to Enhance the Future of Integrative Medicine by sharing Case Studies

By S Raju
Therapeutic vaccines promise a new wave of highly potent and highly specific therapeutic agents designed to work in harmony with patients’ own immune systems.

By Fast Market Research
Recently published research from GlobalData, "Mucopolysaccharidosis Therapeutics - Pipeline Assessment and Market Forecasts to 2017", is now available at Fast Market Research

By Fast Market Research
New Pharmaceuticals research report from GlobalData is now available from Fast Market Research

By Fast Market Research
Recently published research from GlobalData, "Cytomegalovirus (CMV) Retinitis Therapeutics - Pipeline Assessment and Market Forecasts to 2017", is now available at Fast Market Research

By Fast Market Research
New Pharmaceuticals market report from GlobalData: "Uveitis Therapeutics - Pipeline Assessment and Market Forecasts to 2017"

By Fast Market Research
Fast Market Research recommends "Hypercholesterolemia Therapeutics - Pipeline Assessment and Market Forecasts to 2017" from GlobalData, now available

By Fast Market Research
Fast Market Research recommends "Traumatic Brain Injury (TBI) Therapeutics - Pipeline Assessment and Market Forecasts to 2017" from GlobalData, now available

By Fast Market Research
Fast Market Research recommends "Osteoarthritis (OA) Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2017" from GlobalData, now available

By Raju Pillai
This study surveys the market for small–molecules and biologic therapies for diseases caused by disorders of the immune system

By Fast Market Research
New Pharmaceuticals research report from GlobalData is now available from Fast Market Research

By Fast Market Research
New Pharmaceuticals market report from GlobalData: "Tardive Dyskinesia Global Clinical Trials Review, Q1, 2011"



Page:

Page updated every 10 minutes


  1. SiteMap
  2. Contact PRLog
  3. Privacy Policy
  4. Terms of Service
  5. Copyright Notice
  6. About
  7. Advertise
Like PRLog?
9K2K1K
Click to Share